Making money in biotech stocks

Treasurys, bonds, caution and patience with Julia Ostian, Kenio Fontes, and Jack Bowman (0:40) 'Messy' AI stocks to like (10:30) Defense quantum sector (24:15) We have to talk about Uber (33:15) The Netflix Story (41:00)Episode transcriptsFor full access to analyst ratings, stock ...  Show more

Don't sleep on (analog) semiconductors, says Alex King from Growth Investor Pro (1:00) Bullish on Texas Instruments (14:40) Will hyperscaler CapEx forecasts turn out to be true? (23:20)Show Notes:Don't Sleep On SoftwareEpisode transcriptsFor full access to analyst ratings, stock ...  Show more

In this episode, David Lebovitz, Global Strategist, Multi-Asset Solutions, is joined by Stephen Squinto, Chief Investment Officer, J.P. Morgan Life Sciences Private Capital, to discuss the alternative investment landscape, the private biotech market and areas of opportunity in 20 ...  Show more

Gary Vaughan from Daily Stock Picks highlights ETFs and why setting your risk tolerance as investor is important (0:10). How the macro picture affects his portfolio performance (1:10). Tech earnings: Apple's valuation is concerning, Google monetizing AI, but is Microsoft? High fl ...  Show more

Scott shares his thoughts on who stands to win and lose after the SEC’s approval of eleven bitcoin ETFs. He also discusses a scandal in the startup world and explains why there’s enormous opportunity in the secondary market. Finally, he breaks down his investment plans for 2024. ...  Show more

IN THIS EPISODE, YOU'LL LEARN: 10:18 - How to take positions in the market with a $5 upside and a $1 downside. 13:14 - How to make money in spin-offs. 26:45 - How to make money in risk arbitrage and merger securities. 45:57 - How call options work. BOOKS AND RESOURCES Join the ex ...  Show more